- Active not recruitingPHASE3
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
This study is looking at a new way to give risankizumab, a medicine for Crohn's disease, as an injection under the skin. It aims to see how well it works and if it's safe for adults with moderate to severe Crohn's disease.
For: Crohn's DiseaseUnited States · Argentina · Brazil - Active not recruitingPHASE3
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
This study looks at a new medicine called risankizumab for Crohn's disease. We're checking how well it works and if it's safe for people who have already started treatment. It's like a follow-up to see how different doses work and how people feel over time.
For: Crohn's DiseaseUnited States · Argentina · Australia